The stock price of DaVita Healthcare (NYSE: DVA), a medical services company providing kidney dialysis services, has seen a fall of 7% last week, while it is down 10% in a month. The company recently announced its Q3 results with revenue of $2.9 billion, in-line with the consensus estimates.
...read full article on Forbes